Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company's system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient's back, and a personal computer (PC)-based work station for data reconstruction and image processing. The Company's scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. Its scanning capsule employs low-dose X-rays, which allow the system to image the interior lining of the colon even when surrounded by intestinal content. Its capsule transmits information to a receiving device worn on the patient's body that stores the information for off-line analysis.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Symbol: NASDAQ:CHEK
- CUSIP: N/A
- Web: www.check-cap.com
- Market Cap: $31.41 million
- Outstanding Shares: 15,629,000
- 50 Day Moving Avg: $2.09
- 200 Day Moving Avg: $2.25
- 52 Week Range: $0.97 - $3.42
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -2.91
- P/E Growth: 0.00
- Annual Revenue: N/A
- Price / Sales: N/A
- Book Value: $0.51 per share
- Price / Book: 3.94
- EBIDTA: ($8,790,000.00)
- Return on Equity: -84.96%
- Return on Assets: -70.63%
- Current Ratio: 11.01%
- Quick Ratio: 11.01%
- Average Volume: 35,644 shs.
- Beta: -0.27
- Short Ratio: 1.81
Frequently Asked Questions for Check Cap Ltd (NASDAQ:CHEK)
What is Check Cap Ltd's stock symbol?
Check Cap Ltd trades on the NASDAQ under the ticker symbol "CHEK."
How were Check Cap Ltd's earnings last quarter?
Check Cap Ltd (NASDAQ:CHEK) announced its quarterly earnings data on Thursday, March, 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by $0.01. View Check Cap Ltd's Earnings History.
Where is Check Cap Ltd's stock going? Where will Check Cap Ltd's stock price be in 2017?
3 analysts have issued 1 year target prices for Check Cap Ltd's stock. Their forecasts range from $6.00 to $6.00. On average, they anticipate Check Cap Ltd's stock price to reach $6.00 in the next year. View Analyst Ratings for Check Cap Ltd.
What are analysts saying about Check Cap Ltd stock?
Here are some recent quotes from research analysts about Check Cap Ltd stock:
- 1. According to Zacks Investment Research, "Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. " (5/24/2017)
- 2. Rodman & Renshaw analysts commented, "We are initiating coverage of Check-Cap Ltd., a clinical-stage medical diagnostic company developing a next-generation colorectal cancer (C RC) detection system, with a Buy rating and a 12-month price target of $6.00 per share. In our view, the company's ingestible X-ray scanning capsule, the C-Scan?? screening system, is differentiated from other structural visualization methods- e.g., optical colonoscopy, computed tomographic colonography (CTC) and other optical capsules - since it eliminates the troublesome preparatory step of bowel cleansing, which is the primary reason that many people over age 50 choose not to undergo colonoscopy-based CRC screening. In removing the need for laxative prep and allowing people to maintain normal activities during the imaging process, Check-Cap's system could persuade more people to have regular CRC screening as well as seize market share from the existing screening population. Check-Cap's system candeliver structural imaging of the colon without the pain, discomfort and embarrassment due to the invasive process of colonoscopy." (1/19/2017)
Who are some of Check Cap Ltd's key competitors?
Some companies that are related to Check Cap Ltd include Biocept (BIOC), HTG Molecular Diagnostics (HTGM), TrovaGene (TROV), Roka Bioscience (ROKA), TearLab Corp (TEAR), Rosetta Genomics (ROSG), BG Medicine (BGMD), Bio-Reference Laboratories (BRLI), Great Basin Scientific (GBSN), Nanosphere (NSPH), Organovo Holdings (ONVO) and WaferGen Bio-systems (WGBS).
When did Check Cap Ltd IPO?
(CHEK) raised $13 million in an initial public offering on Thursday, February 19th 2015. The company issued 1,200,000 shares at $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group served as the underwriters for the IPO and Feltl and Company was co-manager.
Who owns Check Cap Ltd stock?
Check Cap Ltd's stock is owned by many different of retail and institutional investors. Top institutional investors include Fosun International Ltd (9.87%), Sabby Management LLC (1.61%), Knott David M (1.05%) and Tredje AP fonden (0.29%). View Institutional Ownership Trends for Check Cap Ltd.
Who sold Check Cap Ltd stock? Who is selling Check Cap Ltd stock?
Who bought Check Cap Ltd stock? Who is buying Check Cap Ltd stock?
How do I buy Check Cap Ltd stock?
Shares of Check Cap Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Check Cap Ltd stock cost?
One share of Check Cap Ltd stock can currently be purchased for approximately $2.01.
Earnings History for Check Cap Ltd (NASDAQ:CHEK)Earnings History by Quarter for Check Cap Ltd (NASDAQ:CHEK)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Check Cap Ltd (NASDAQ:CHEK)
Current Year EPS Consensus Estimate: $-0.63 EPS
Next Year EPS Consensus Estimate: $-0.69 EPS
Dividend History for Check Cap Ltd (NASDAQ:CHEK)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Check Cap Ltd (NASDAQ:CHEK)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Check Cap Ltd (NASDAQ:CHEK)
Latest Headlines for Check Cap Ltd (NASDAQ:CHEK)
|Check Cap Ltd (CHEK) Rating Increased to Buy at Zacks Investment Research|
www.americanbankingnews.com - May 24 at 5:46 PM
|Check Cap Ltd (CHEK) Downgraded to Hold at Zacks Investment Research|
www.americanbankingnews.com - May 23 at 6:16 PM
|Check-Cap and GE Healthcare Achieve Development Milestone in High-volume X-Ray Capsule Manufacturing Collaboration|
finance.yahoo.com - May 9 at 8:17 AM
|Check-Cap Reports First Quarter 2017 Financial Results|
finance.yahoo.com - May 9 at 8:17 AM
|Check Cap (CHEK) Earns Media Impact Rating of -0.12|
www.americanbankingnews.com - May 2 at 12:52 PM
|Check Cap (CHEK) Earning Somewhat Critical Press Coverage, Report Finds|
www.americanbankingnews.com - April 29 at 8:28 AM
|Check Cap Ltd (CHEK) Expected to Post Earnings of -$0.16 Per Share|
www.americanbankingnews.com - April 29 at 1:14 AM
|Check Cap (CHEK) Earning Somewhat Critical Media Coverage, Study Shows|
www.americanbankingnews.com - April 16 at 9:04 AM
|Zacks: Analysts Expect Check Cap Ltd (CHEK) to Announce -$0.16 Earnings Per Share|
www.americanbankingnews.com - April 7 at 8:03 PM
|Zacks: Analysts Set $5.33 Target Price for Check Cap Ltd (CHEK)|
www.americanbankingnews.com - April 4 at 12:28 AM
|Check-Cap (CHEK) Presents At 29th Annual ROTH Conference 2017|
seekingalpha.com - March 15 at 4:38 PM
|CHECK-CAP LTD Financials|
finance.yahoo.com - March 15 at 4:38 PM
|Check Cap Ltd (CHEK) PT Set at $6.00 by Maxim Group|
www.americanbankingnews.com - March 12 at 10:51 PM
|Check Cap Ltd (CHEK) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS|
www.americanbankingnews.com - March 10 at 11:04 AM
|Form 6-K Check-Cap Ltd For: Mar 09 - StreetInsider.com|
www.streetinsider.com - March 9 at 10:04 PM
|Check-Cap Reports Fourth Quarter and Fiscal Year 2016 Financial Results|
finance.yahoo.com - March 9 at 4:52 PM
|Check-Cap to Present at the 29th Annual ROTH Conference on March 14, 2017|
finance.yahoo.com - March 1 at 11:16 AM
|Check-Cap to Present at the 2nd Annual Disruptive Growth & Healthcare Conference on February 15|
finance.yahoo.com - February 8 at 4:35 PM
|Check-Cap Ltd. to Webcast, Live, at VirtualInvestorConferences.com on Thursday, February 2|
us.rd.yahoo.com - January 30 at 10:03 PM
|Check-Cap Ltd. to Webcast, Live, at VirtualInvestorConferences.com on Thursday, February 2 - Yahoo Finance|
finance.yahoo.com - January 30 at 5:02 PM
|Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd|
finance.yahoo.com - January 30 at 5:02 PM
|Coverage initiated on Check-Cap by Rodman & Renshaw|
finance.yahoo.com - January 19 at 5:30 PM
|Check-Cap Enrolls First Patient in Clinical Trial to Support CE Mark of Its C-Scan® Colorectal Cancer Screening System|
finance.yahoo.com - January 17 at 9:03 AM
|Keeping the Faith (Even After a 99% Wipeout) for Shareholders|
www.bloomberg.com - December 8 at 6:25 AM
Check Cap Ltd (CHEK) Chart for Sunday, May, 28, 2017